First Eagle Investment Management LLC Raises Stock Holdings in Envista Holdings Corporation $NVST

First Eagle Investment Management LLC increased its stake in Envista Holdings Corporation (NYSE:NVST) by 10.6% during the 4th quarter, Holdings Channel reports. The firm owned 235,000 shares of the company’s stock after purchasing an additional 22,500 shares during the quarter. First Eagle Investment Management LLC’s holdings in Envista were worth $5,102,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Tudor Investment Corp ET AL bought a new stake in shares of Envista during the 3rd quarter worth $1,664,000. ARGA Investment Management LP bought a new position in Envista in the third quarter valued at $950,000. Massachusetts Financial Services Co. MA increased its stake in Envista by 22.0% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,905,149 shares of the company’s stock valued at $59,178,000 after acquiring an additional 523,949 shares during the last quarter. Jupiter Asset Management Ltd. raised its position in Envista by 24.6% during the third quarter. Jupiter Asset Management Ltd. now owns 1,349,042 shares of the company’s stock valued at $27,480,000 after purchasing an additional 266,671 shares in the last quarter. Finally, Fox Run Management L.L.C. bought a new stake in Envista during the third quarter worth about $880,000.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Weiss Ratings cut Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday. Barclays increased their price target on shares of Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday, February 11th. Zacks Research downgraded shares of Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. William Blair upgraded shares of Envista from a “hold” rating to an “outperform” rating in a report on Friday, February 6th. Finally, Leerink Partners set a $35.00 price objective on shares of Envista and gave the company an “outperform” rating in a research note on Friday, February 6th. Six analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $28.83.

Envista Stock Performance

Shares of NVST stock opened at $23.94 on Thursday. The company has a market capitalization of $3.89 billion, a P/E ratio of 58.38, a PEG ratio of 1.52 and a beta of 0.92. Envista Holdings Corporation has a fifty-two week low of $16.41 and a fifty-two week high of $30.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. The stock has a 50 day moving average price of $26.11 and a two-hundred day moving average price of $24.18.

Envista (NYSE:NVST) last issued its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. The firm had revenue of $705.50 million for the quarter, compared to analysts’ expectations of $680.04 million. During the same quarter last year, the business earned $0.24 earnings per share. The business’s revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts expect that Envista Holdings Corporation will post 1.43 earnings per share for the current year.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.